# SDAMLO
> **NDA219531** · New Drug Application · Sponsor: BRILLIAN PHARMA · Approved 2025-07-24
## Drug
- **FDA Application Number:** NDA219531
- **Application type:** New Drug Application
- **Brand name:** SDAMLO
- **Generic name:** AMLODIPINE
- **Active ingredients:** AMLODIPINE BESYLATE
- **Dosage form:** FOR SOLUTION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** BRILLIAN PHARMA
- **Manufacturer:** Pangea Pharmaceuticals, LLC
- **First approval:** 2025-07-24
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219531)
---
*MORVS · CC0 1.0*